Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Anixa Biosciences Announces $5 Million Share Repurchase Program
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
97.62m
Last Price
$3.05
52-Week Range
$2.145 - $5.13
07/26/2024 04:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808